title: Cohort studies (and skin cancer) never come alone.
abstract: A previous keratinocyte carcinoma is probably the strongest predictor of developing new keratinocyte carcinomas, which makes these patients an interesting population for prevention interventions. Investing in large cohort studies and consortia might increase the validity of observational findings and should stimulate scientists to investigate the underlying mechanisms in detail.
authors: Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
authors: Joris A C
authors: JAC
authors: Verkouteren
authors: Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
authors: Robert J T
authors: RJT
authors: van der Leest
authors: Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands. Electronic address: t.nijsten@erasmusmc.nl.
authors: Tamar
authors: T
authors: Nijsten
mesh_terms: D002280:Basal Cell Carcinoma / Q000473:pathology*; D002294:Carcinoma, Squamous Cell / Q000473:pathology*; D005260:Female; D006801:Humans; D015603:Keratinocytes / Q000473:pathology*; D008297:Male; D012878:Skin Neoplasms / Q000473:pathology*